Log in
Enquire now
‌

US Patent 11014991 Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody

Patent 11014991 was granted and assigned to Apogenix on May, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present invention relates to a specific CD95L antibody and to the use thereof in the treatment or diagnosis of diseases involving CD95L-induced signalling, e.g. cancer diseases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11014991 Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.